BioSense 2.0: Summer Successes
BioSense Program Awards Cooperative Agreements to 35 Jurisdictions
The BioSense Program awarded more than $7M to 35 applicants out of the pool of applicants, which included state, local, territorial and tribal (SLTT) groups. This is the first year that the BioSense Program issued its own cooperative agreement opportunity to SLTT groups. These agreements were awarded in September 2012, and will be funded each year for 3 years (FY2012-2014). Funding for these agreements came out of technology cost savings realized by the program this year, as it was the first in HHS to move completely to the secure Internet GovCloud.
BioSense 2.0 Builds Community Governance
The BioSense 2.0 Governance group has also been active developing feedback mechanisms for the community, and will be working on developing their own section of the BioSense 2.0 information site (www.biosense2.org). The governance is comprised of members of local and state health departments, CDC, other federal agencies and partners, and private vendor groups.
As of October 2012, 32 jurisdictions have signed a Data Use Agreement to participate in BioSense 2.0, 24 more than ever participated in BioSense 1.0. These jurisdictions encompass a variety of perspectives, as well as a range of different experience levels. Many have never performed syndromic surveillance before, and are now increasing their capacity and ability to better respond to public health issues through funding from the BioSense Program. Onboarding and technical assistance is performed by the CDC BioSense Team on a daily basis, and is available to all State, Local, Tribal, and Territorial Health departments by contacting info@biosen.se.
BioSense 2.0:
Moving Forward, Fall 2012
BioSense
Program Begins “Onboarding” Jurisdictions
BioSense 2.0 will continue to enhance national
biosurveillance capabilities and all-hazards preparedness by building a
system-of-systems in partnership with state and local health jurisdictions. As on-boarding of syndromic surveillance
health data feeds occurs, the technical assistance team will make data
connections with minimal health department staff time and resource commitments.
BioSense 2.0’s flexible technical specifications make this possible. A wide
variety of data file formats and transmission protocols can be received,
including HL7 messages from electronic health record technologies certified for
Meaningful Use. Syndromic surveillance data from individual hospitals, hospital
groups, Health Information Exchanges (HIEs), state and local surveillance
systems, and vendor operated surveillance systems are all compatible with the
BioSense 2.0 platform. For more information on the technical requirements,
please visit www.biosense2.org.
What
are the initial benefits of BioSense 2.0 to STLT users?
- Greater capacity for data management and storage
- Cost saving in information technology and infrastructure
- Greater and more timely access to regional and national public health surveillance data
- Greater access to peers for sharing information, knowledge and best practice
- Greater opportunity for STLTs to develop biosurveillance capabilities and increase situational awareness
The governance is comprised of members of local and state health departments, CDC, other federal agencies and partners, and private vendor groups.
ReplyDelete